SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Jan-23 4:49 PM View: | Chemomab Therapeutics Ltd. (CMMB) | 03-Jan-23 | Sale | 336,900 | $3.58 | $1,207,760.00 | (13%) 2.58M to 2.24M | |
25-Jun-21 7:08 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 25-Jun-21 | Market Sale | 15,989,900 | $1.21 | $19,347,800.00 | (65%) 24.59M to 8.6M | |
25-Jun-21 7:08 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 24-Jun-21 | Market Sale | 319,255 | $1.38 | $440,572.00 | (1%) 24.91M to 24.59M | |
25-Jun-21 7:08 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 23-Jun-21 | Market Sale | 841,650 | $1.36 | $1,144,640.00 | (3%) 25.75M to 24.91M | |
13-May-21 6:34 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 11-May-21 | Exercise (in-the money or at-the-money) | 31,944 | $0.65 | $20,836.40 | < 1% 51.45M to 51.48M | |
18-Mar-21 9:59 PM View: | Chemomab Therapeutics Ltd. (CMMB) | 16-Mar-21 | Grant | 288,170 | $17.35 | $4,999,750.00 | 13% 2.29M to 2.58M | |
04-Dec-20 5:17 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 02-Dec-20 | Market Sale | 103,200 | $21.60 | $2,229,120.00 | (58%) 176.85K to 73.65K | 29% |
03-Nov-20 4:14 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 30-Oct-20 | Acquisition (other) Duplicate | 1,943,730 | -- | -- | 8% 23.77M to 25.72M | |
02-Jul-20 4:25 PM View: | 9 Meters Biopharma, Inc. (NMTR) | 30-Jun-20 | Conversion Duplicate | 6,786,500 | -- | -- | 40% 16.99M to 23.77M | |
06-May-19 5:30 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 02-May-19 | Market Purchase Duplicate | 646,204 | $3.10 | $2,003,230.00 | 25% 2.54M to 3.18M | (69%) |
11-May-17 4:13 PM View: | Eledon Pharmaceuticals, Inc. (NVUS) | 09-May-17 | Grant | 2,537,110 | -- | -- | 100% 0 to 2.54M |